Provider attitudes and satisfaction with rapid preoperative point-of-care COVID-19 testing using ID NOW™

Lee, Susan M.; Meyler, Paula; Mozel, Michelle; Choi, J. S.; Tauh, Tonia

doi:10.1007/s12630-021-02073-4

Cited by 6 publications

(2 citation statements)

References 43 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the pre-operative setting, POC testing allowed the rescheduling of elective surgeries of asymptomatic patients who test positive for SARS-CoV-2, avoiding the risk of post-surgical morbidity and mortality or potential nosocomial transmissions ( 8 ). POC testing was also shown to increase a sense of workplace safety and improve morale ( 9 ) and was easily incorporated into pre-operative and occupational health decision-making ( 9 – 11 ). Future studies should consider evaluating the impact of NAAT-RDTs in each setting, comparing individuals who present with and without symptoms, as well as considerations for costs compared to laboratory testing.…”

Section: Discussionmentioning

confidence: 99%

Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test

Simms,

McCracken,

Hatchette

et al. 2023

Microbiol Spectr

View full text Add to dashboard Cite

In hospitals during the COVID-19 pandemic, laboratory testing was important to reduce SARS-CoV-2 transmissions, particularly for high-risk settings like the emergency department and pre-operative settings and for the safe return to work of exposed healthcare workers (HCWs). For these applications, delayed test results from laboratory nucleic acid amplification tests (NAATs) posed a barrier to maximizing efficient patient flow and minimizing staffing shortages. This quality improvement project sought to evaluate the performance of the Lucira Check-It COVID-19 Test, a rapid diagnostic test that used NAAT technology (NAAT-RDT). Using 10-fold serial dilutions of SARS-CoV-2, the analytical sensitivity of the NAAT-RDT was assessed against standard NAATs used for routine diagnostic testing. Clinical performance was assessed at two Nova Scotia hospitals in 405 cases with paired swabs tested by NAAT-RDT and laboratory-based NAATs. These represented three distinct populations: patients presenting to the emergency department ( n = 208), patients in the pre-operative setting ( n = 158), and patients presenting to community testing sites ( n = 38). The analytical sensitivity of the NAAT-RDT and other laboratory NAATs was comparable. During clinical evaluation, the overall sensitivity and specificity were 92.9% and 98.3%, respectively, with little variation between settings. The Lucira NAAT-RDT is a portable and self-contained device that provides an easily interpreted result within 30 minutes following a bilateral nasal swab collection. Its performance was shown to be acceptable for use in three settings in this quality improvement project, facilitating patient flow and management. IMPORTANCE In hospitals during the COVID-19 pandemic, laboratory testing was important to reduce SARS-CoV-2 transmissions, while facilitating patient flow in the emergency department and pre-operative settings, and allowing for the safe return to work of exposed healthcare workers. Delayed test results from laboratory nucleic acid amplification tests (NAATs) posed a barrier to maximizing efficient patient flow and minimizing staffing shortages. This quality improvement project sought to evaluate the analytical and clinical performance of the Lucira Check-It COVID-19 Test, a point-of-care test that used NAAT technology, in the perioperative setting, emergency department, and community testing sites. We found the Lucira Check-It to have comparable performance to laboratory NAATs. It can be employed with little training for specimen collection, processing, and interpretation, and at a cost justifiable from the resources saved from avoiding sample transport and laboratory testing.

show abstract

Section: Discussionmentioning

confidence: 99%

Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test

Simms,

McCracken,

Hatchette

et al. 2023

Microbiol Spectr

View full text Add to dashboard Cite

show abstract

“… 19 , 20 It has been shown that the use of COVID-19 POCT has positively affected healthcare providers through improved morale, and reduced worry associated with COVID-19 without disruption of workflow. 21 The acceptance of COVID-19 POC tests by both healthcare providers and patients will, optimistically, improve the way that POCT is perceived, and contribute to growing adoption rates. The successful implementation of POC tests proven to be cost-effective demands transformation and integration of services across healthcare organizations.…”

Section: Introductionmentioning

confidence: 99%

How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries

Lingervelder

Koffijberg

Emery

et al. 2021

Int J Health Policy Manag

View full text Add to dashboard Cite

Background: In some countries, such as the Netherlands and Norway, point of care testing (POCT) is more widely implemented in general practice compared to countries such as England and Australia. To comprehend what is necessary to realize the benefits of POCT, regarding its integration in primary care, it would be beneficial to have an overview of the structure of healthcare operations and the transactions between stakeholders (also referred to as value networks). The aim of this paper is to identify the current value networks in place applying to POCT implementation at general practices (GPs) in England, Australia, Norway and the Netherlands and to compare these networks in terms of seven previously published factors that support the successful implementation, sustainability and scale-up of innovations. Methods: The value networks were described based on formal guidelines and standards published by the respective governments, organizational bodies and affiliates. The value network of each country was validated by at least two relevant stakeholders from the respective country. Results: The analysis revealed that the biggest challenge for countries with low POCT uptake was the lack of effective communication between the several organizations involved with POCT as well as the high workload for GPs aiming to implement POCT. It is observed that countries with a single national authority responsible for POCT have a better uptake as they can govern the task of POCT roll-out and management and reduce the workload for GPs by assisting with set-up, quality control, training and support. Conclusion: Setting up a single national authority may be an effective step towards realizing the full benefits of POCT. Although it is possible for day-to-day operations to fall under the responsibility of the GP, this is only feasible if support and guidance are readily available to ensure that the workload associated with POCT is limited and as low as possible.

show abstract

Provider attitudes and satisfaction with rapid preoperative point-of-care COVID-19 testing using ID NOW™

Lee

Meyler

Mozel

et al. 2021

Can J Anesth/J Can Anesth

Self Cite

View full text Add to dashboard Cite

Purpose Healthcare workers have experienced high levels of anxiety during the COVID-19 pandemic, particularly when caring for patients with unknown infection status. We trialled rapid preoperative point-of-care COVID-19 testing using the Abbott ID NOW TM COVID-19 for clinical validation in an urgent surgical population at a single centre in British Columbia, Canada. Here, we sought to determine the opinions and beliefs of operating room (OR) staff on the usefulness and effectiveness of point-of-care tests on workflow and wellbeing in the OR. Methods This descriptive study used a mixed-methods cross-sectional survey of all OR staff (nurses, anesthesiologists, surgeons, and ancillary staff) at a single centre after using the ID NOW for three months. Outcomes of interest included healthcare worker satisfaction with the ID NOW, effects on OR workflow, and worries about COVID-19 transmission.

show abstract

Provider attitudes and satisfaction with rapid preoperative point-of-care COVID-19 testing using ID NOW™

Cited by 6 publications

References 43 publications

Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test

Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test

How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries

Provider attitudes and satisfaction with rapid preoperative point-of-care COVID-19 testing using ID NOW™

Contact Info

Product

Resources

About